Evidence map›Paper›PMID 16796386›Full record

ReviewThe AAPS journal2006

Modulating inhibitory ligand-gated ion channels.

Michael Cascio

Abstract readReview
In one paragraph

Review in The AAPS journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences.International urogynecology journal and pelvic floor dysfunction · 2008
    Pooled it
  2. Article
  3. Article
  4. Receptor targets of amacrine cells.Visual neuroscience · 2012
    Review
  5. Article
  6. Article
  7. Article
  8. Chloride channels as drug targets.Nature reviews. Drug discovery · 2009
    Review
  9. Article
  10. Ionotropic glutamate receptors & CNS disorders.CNS & neurological disorders drug targets · 2008
    Review
  11. Article
  12. Ion channel pharmacology.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Michael CascioDepartment of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. cascio@pitt.edu
University of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glycine and gamma-aminobutyric acid receptors (GlyR and GABA(A)R, respectively) are the major inhibitory neurotransmitter-gated receptors in the central nervous system of animals. Given the important role of these receptors in neuronal inhibition, they are prime targets of many therapeutic agents and are the object of intense studies aimed at correlating their structure and function. In this review, the structure and dynamics of these and other homologous members of the nicotinicoid superfamily are described. The modulatory actions of the major biological macromolecules that bind and allosterically affect these receptors are also discussed.

Indexed as

AlcoholsAnestheticsBarbituratesIon Channel GatingIon ChannelsLigandsLipidsReceptors, GABAReceptors, GlycineReceptors, NicotinicSteroidsAlcoholsAnestheticsBarbituratesIon ChannelsLigandsLipidsReceptors, GABAReceptors, GlycineReceptors, NicotinicSteroids

Identifiers

PMID16796386
PMCPMC3231573
OpenAlexW2081295409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.